In conclusion, we demonstrated that overexpression of miR-155, one of the most significantly altered miRNAs in breast cancer, is related to clinical stage, lymph node metastasis, higher Ki-67 and hormone receptor status of breast cancer patients. Here, MKI67 is linked to metastatic malignant neoplasm in the lymph nodes.